Ads
related to: Dupixent- Pricing And Insurance
Check Copay Eligibility
Learn About Payment Options
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Injection Support Center
Get Help With Taking DUPIXENT®
View Injection Resources Now
- Patient Support
Access DUPIXENT MyWay®
Get Patient Journey Support Today
- Pricing And Insurance
Search results
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 7 days agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
ASLAN Pharmaceuticals Ltd ADR
NewsHeater· 1 hour agoZacks Investment Research reported 2024-03-12 that ASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with eczema, who have previously been treated with ...
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
Zacks via Yahoo Finance· 7 days agoRegeneron (REGN) obtains FDA approval for Praluent as an adjunct to diet and other LDL-C, lowering...
Three Trials Examine Dupilumab in Moderate-to-Severe Asthma
MedPage Today· 7 days agoVESTIGE, a phase IV trial which evaluated the effect of dupilumab on airway remodeling parameters...
Tuesday's analyst calls: Carvana gets an upgrade, Coinbase momentum to continue?
CNBC· 7 days agoPlease refresh every 20-30 minutes to view the latest posts.) An online car seller and a crypto...
Madrigal Can Market the First Drug for Obesity-Scarred Livers. The Stock Soars.
Barrons.com· 4 days agoThe first drug for an obesity-driven liver disease got U.S. marketing approval Thursday. Shares of...
Oracle, Dollar General upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 7 days agoTop 5 Initiations: Bernstein initiated coverage of Regeneron (REGN) with an Outperform rating and...
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
InvestorPlace· 6 days agoBiotech stocks are not for investors with a low-risk tolerance. Investing in biotech stocks can be...
Wednesday's analyst calls: Nvidia gets a price target hike, big Tesla downgrade
CNBC· 6 days agoPlease refresh every 20-30 minutes to view the latest posts.) Two megacap stocks were in focus...
Sanofi (NASDAQ:SNY) Shares Bought by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 23 hours agoB. Riley Wealth Advisors Inc. increased its holdings in Sanofi (NASDAQ:SNY – Free Report) by 25.5% in the third quarter, according to its most recent filing with the Securities and Exchange ...
Ad
related to: Dupixent